- Home
- SELF vs MIRA Comparison
SELF vs MIRA Comparison
Compare SELF & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SELF | MIRA |
|---|---|---|
| Founded | 1983 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.3M | 50.3M |
| IPO Year | 1997 | 2023 |
Fundamental Metrics
Financial Performance| Metric | SELF | MIRA |
|---|---|---|
| Price | $4.98 | $1.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 31.8K | ★ 144.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.76% | N/A |
| EPS Growth | N/A | ★ 20.31 |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $12,530,280.00 | N/A |
| Revenue This Year | $1.59 | N/A |
| Revenue Next Year | $1.62 | N/A |
| P/E Ratio | $33.43 | ★ N/A |
| Revenue Growth | ★ 2.79 | N/A |
| 52 Week Low | $4.73 | $0.80 |
| 52 Week High | $5.83 | $2.45 |
Technical Indicators
Market Signals| Indicator | SELF | MIRA |
|---|---|---|
| Relative Strength Index (RSI) | 44.66 | 43.64 |
| Support Level | $4.98 | $1.15 |
| Resistance Level | $5.09 | $1.35 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 25.00 | 68.42 |
Price Performance
Historical ComparisonAbout SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.